Results 141 to 150 of about 29,624,517 (312)

Tecnazene : health and safety guide

, 1988
Companion volume to: Environmental health criteria ; 42Published by the World Health Organization for the International Programme on Chemical Safety28 p.The Spanish version is published by PAHO: https://iris.paho.org/handle/10665.2 ...
World Health Organization, International Programme on Chemical Safety   +1 more
core  

Mental Health Issues and International Students

JANZSSA, 2011
In November 2011, Sean Murray (WA ANZSSA Convenor and Head of Counselling and Disability Services at Curtin) and I both attended the ISANA Conference being held at the Crown Casino complex in Melbourne.
Jim Elliott
doaj  

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Atrazine : health and safety guide

, 1990
Published by the World Health Organization for the International Programme on Chemical Safety22 ...
World Health Organization, International Programme on Chemical Safety   +1 more
core  

Challenges and opportunities with adapting international health care quality indicators to local contexts: A descriptive case study. [PDF]

Int J Qual Health Care
Vedel I, Cetin-Sahin D, Arsenault-Lapierre G, Bolster-Foucault C, Ilali M, Quesnel-Vallée A.   +5 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Captan : health and safety guide

, 1990
Published by the World Health Organization for the International Programme on Chemical Safety20 ...
World Health Organization, International Programme on Chemical Safety   +1 more
core  

Representing Traditional East Asian Medicine in International Health Informatics Standards: A Scoping Review. [PDF]

Healthcare (Basel)
Lee S, Woo Y, Lee S.
europepmc   +1 more source

Correction: Leaving no one behind on the road to Universal Health Coverage: The Kerala story

International Journal for Equity in Health
International Journal for Equity in Health
doaj   +1 more source

International Health

American Journal of Public Health and the Nations Health, 1929
openaire   +3 more sources